SCHEMBL17260550

SCHEMBL17260550

CN(C)c1ccc2c(-c3c(F)c(F)c(F)c(F)c3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.59
▸ BLM P54132 2/20 0.59
▸ KMT2A Q03164 2/20 0.59
▸ THRB P10828 1/20 0.59
▸ RECQL P46063 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.59
▸ P2RY6 Q15077 1/20 0.58
▸ ITPR1 Q14643 1/20 0.45
▸ CA12 O43570 3/20 0.42
▸ CA1 P00915 3/20 0.42
▸ CA2 P00918 3/20 0.42
▸ CA9 Q16790 3/20 0.42
▸ HTR3A P46098 1/20 0.42
▸ USP2 O75604 2/20 0.41
▸ APAF1 O14727 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ P2RY2 P41231 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17260549 0.89 MEN1 (0.53) MEN1BLMKMT2ATHRBRECQL
SCHEMBL13933225 0.88 MEN1 (0.71) MEN1BLMKMT2ATHRBRECQL
Tetramethylrhodamine SCHEMBL29838750 0.80 P2RY6 (0.67) MEN1BLMKMT2ATHRBRECQL
Tetramethylrhodamine SCHEMBL13815486 0.80 P2RY6 (0.67) MEN1BLMKMT2ATHRBRECQL
SCHEMBL20200017 0.79 P2RY6 (0.66) MEN1BLMKMT2ATHRBRECQL
Tetramethylrhodamine SCHEMBL29587824 0.79 P2RY6 (0.66) MEN1BLMKMT2ATHRBRECQL
Tetramethylrhodamine SCHEMBL30091907 0.79 P2RY6 (0.66) MEN1BLMKMT2ATHRBRECQL
SCHEMBL21878583 0.78 P2RY6 (0.67) MEN1BLMKMT2ATHRBRECQL
SCHEMBL30291869 0.78 MEN1 (0.56) MEN1BLMKMT2ATHRBRECQL
SCHEMBL31756958 0.78 P2RY6 (0.69) MEN1BLMKMT2ATHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3502693-A1 CELL TRACKING REAGENTS AND THEIR METHODS OF USE Life Technologies Corporation (US) 2019-06-26 — — EP disclosed
EP-3143400-A1 CELL TRACKING REAGENTS AND THEIR METHODS OF USE Life Technologies Corporation (US) 2017-03-22 — — EP disclosed
US-20170044372-A1 CELL TRACKING REAGENTS AND THEIR METHODS OF USE Life Technologies Corporation 2017-02-16 — — US disclosed
WO-2015175873-A1 CELL TRACKING REAGENTS AND THEIR METHODS OF USE Life Technologies Corporation (US) 2015-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170044372-A1 CELL TRACKING REAGENTS AND THEIR METHODS OF USE MKI67, DCX, NES MEN1 2254/4885BLM 2030/4885KMT2A 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback